This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
SHEEP ANTI HUMAN 14-3-3 PROTEIN
catalog :
7835-1009
quantity :
1 ml
clonality :
polyclonal
host :
domestic sheep
conjugate :
nonconjugated
reactivity :
human
application :
western blot
product information
Entity Category :
Antibodies
Product Code :
7835-1009
Description :
SHEEP ANTI HUMAN 14-3-3 PROTEIN
Specificity :
14-3-3
Target Species :
Human
Host :
Sheep
Format :
Purified
Isotypes :
Polyclonal IgG
Applications :
WB
Application Types :
Western Blotting
Quantity :
1 ml
Quantity Value :
1 ml
Quantity Type :
ml
GO Accessions :
GO:0005159, GO:0005737, GO:0006713, GO:0006886, GO:0016563, GO:0019899, GO:0019904, GO:0035259, GO:0042921, GO:0048167, GO:0050774, GO:0005634, GO:0005813, GO:0019904, GO:0045892, GO:0047485, GO:0001836, GO:0005615, GO:0005634, GO:0005737, GO:0008426, GO:0008630, GO:0019904, GO:0043154, GO:0000086, GO:0005829, GO:0005080, GO:0005159, GO:0008426, GO:0009966, GO:0045664, GO:0048167, GO:0000186, GO:0005829, GO:0005813, GO:0007173, GO:0007265, GO:0007411, GO:0008286, GO:0008629, GO:0008633, GO:0016071, GO:0019904, GO:0035308, GO:0042470, GO:0042826, GO:0050815, GO:0048011, GO:0048471, GO:0051220
GO Terms :
activation of MAP kinase kinase activity, activation of MAP/ERK kinase kinase, activation of MAPKK activity during sporulation, amino-terminal binding, amino-terminus binding, axon chemotaxis, axon growth cone guidance, axon pathfinding, cell nucleus, cytoplasmic retention of protein, cytoplasmic sequestration of protein, cytoplasmic storage of protein, daf-2 receptor signaling pathway, diacylglycerol-activated phospholipid-dependent PKC inhibitor activity, diacylglycerol-activated phospholipid-dependent protein kinase C inhibitor activity, down regulation of caspase activity, down regulation of dendrite morphogenesis, down regulation of protein amino acid dephosphorylation, down regulation of transcription, DNA-dependent, downregulation of caspase activity, down-regulation of caspase activity, downregulation of dendrite morphogenesis, down-regulation of dendrite morphogenesis, downregulation of protein amino acid dephosphorylation, down-regulation of protein amino acid dephosphorylation, down-regulation of transcription, DNA-dependent, downregulation of transcription, DNA-dependent, EGF receptor signaling pathway, EGF receptor signalling pathway, EGFR signaling pathway, epidermal growth factor receptor signalling pathway, glucocorticoid breakdown, glucocorticoid catabolism, glucocorticoid degradation, glucocorticoid receptor signalling pathway, GO:0001719, GO:0003710, GO:0004863, GO:0005067, GO:0007255, GO:0008040, GO:0035466, IGF receptor binding, induction of pro-apoptotic gene products, inhibition of caspase activation, inhibition of caspase activity, inhibition of dendrite morphogenesis, inhibition of protein amino acid dephosphorylation, inhibition of transcription, DNA-dependent, insulin receptor signalling pathway, insulin-like growth factor, insulin-like growth factor receptor ligand, intercellular space, maintenance of protein location in cytoplasm, mRNA metabolism, negative regulation of caspase activation, negative regulation of cellular transcription, DNA-dependent, negative regulation of protein amino acid dephosphorylation, nerve growth factor receptor signalling pathway, NGF receptor signaling pathway, NGF receptor signalling pathway, NH2-terminal binding, NH2-terminus binding, N-terminal binding, N-terminal end binding, phosphoserine/phosphothreonine binding, PKC binding, PKC inhibitor activity, positive regulation of MAPKK activity, protein domain-specific binding, Ras mediated signal transduction, regulation of signaling pathway, regulation of signalling pathway, retention of protein in cytoplasm, sequestering of protein in cytoplasm, sequestration of protein in cytoplasm, storage of protein in cytoplasm, transcription activating factor, transcriptional activator activity
Uniprot Accessions :
P27348, P31946, P31947, P61981, P62258, P63104, Q04917
Gene :
SFN, YWHAB, YWHAE, YWHAG, YWHAH, YWHAQ, YWHAZ
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=10971, http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=2810, http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=7529, http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=7531, http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=7532, http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=7533, http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=7534
EntityFormats :
Purified
UNSPSC :
41116161
Concentration :
Ig concentration 2.5 mg/ml
Product Form :
Purified Ig - liquid
PrimarySecondary :
Primary
NotForSaleInCountries :
Canada
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.